Parenteral and Enteral Nutrition

Metabolic consequences of inadequate nutrition and the physiologic basis for nutritional support

• Protein-energy malnutrition and metabolic adaptation: When oral intake is inadequate, the body undergoes a complex metabolic shift. Initially, hepatic glycogenolysis provides glucose for 8-12 hours, but glycogen stores become depleted. Subsequently, gluconeogenesis from lactate, glycerol, and amino acids (particularly alanine via the Cori cycle) becomes the primary mechanism for maintaining blood glucose. Prolonged starvation leads to proteolysis with breakdown of skeletal muscle and visceral proteins to provide amino acid substrates. This process results in loss of lean body mass, impaired wound healing, compromised immune function (due to loss of lymphocyte populations and antibody production), decreased synthesis of acute phase reactants, and altered gastrointestinal barrier function. PN and EN interrupt this catabolic cascade by providing exogenous macronutrients that suppress endogenous glucose production and protein breakdown.

• Lipid metabolism and ketosis: During prolonged fasting, lipolysis increases with elevated free fatty acid mobilization from adipose tissue. The liver converts fatty acids to ketone bodies (acetoacetate, beta-hydroxybutyrate) through beta-oxidation, which become the preferred fuel for the brain and skeletal muscle, reducing but not eliminating the need for gluconeogenesis. PN providing adequate carbohydrate and lipid in appropriate ratios suppresses this process and reduces protein catabolism. The ratio of carbohydrate to lipid in PN formulations (typically 60-70% carbohydrate, 30-40% lipid calories) is designed to optimize this metabolic effect.

• Gut barrier dysfunction and bacterial translocation: The intestinal epithelium requires continuous nutrient supply, particularly glutamine (a preferential fuel for enterocytes), arginine (substrate for nitric oxide synthesis, critical for mucosal blood flow), and nucleotides. With prolonged PN use and GI tract disuse, intestinal mucosal atrophy occurs with loss of villous height, decreased absorptive surface area, reduced tight junction protein expression (including zonula occludens-1), and diminished production of secretory IgA. These changes increase intestinal permeability and allow translocation of viable bacteria and endotoxin across the epithelial barrier, potentially precipitating sepsis and systemic inflammation (bacterial translocation hypothesis). This is a fundamental reason why EN is preferred when feasible—maintaining enteral flow preserves mucosal integrity and barrier function. Even small amounts of EN ("trophic feeding" at 10-20 mL/hr) can prevent this atrophy.

• Immune system dysfunction in malnutrition: Malnutrition impairs both innate and adaptive immunity. T-cell lymphopenia develops with reduced delayed-type hypersensitivity responses (measured by skin antigen testing). Neutrophil function is impaired with reduced chemotaxis, phagocytosis, and bactericidal activity. Complement levels decline. Antibody production decreases. These immune deficits are partially reversed by providing adequate nutrition, with immune recovery requiring protein (particularly branched-chain amino acids and arginine) and micronutrients (zinc, selenium, vitamins A, C, E). This underlies the use of immunonutrient formulas enriched with glutamine, arginine, omega-3 fatty acids, and nucleotides in critically ill patients.

• Micronutrient deficiencies and metabolic dysfunction: Prolonged inadequate nutrition leads to specific micronutrient deficiencies that impair critical enzymatic and structural functions. Thiamine deficiency causes impaired carbohydrate metabolism and Wernicke's encephalopathy (particularly risk in refeeding). Phosphate depletion causes muscle weakness, rhabdomyolysis, and impaired ATP production. Magnesium and potassium depletion cause arrhythmias and myopathy. Zinc deficiency impairs wound healing and immune function. Selenium deficiency impairs glutathione peroxidase synthesis, reducing antioxidant defense. These deficiencies must be corrected during nutritional repletion.

• Refeeding syndrome pathophysiology: When nutrition is resumed (whether EN or PN) after prolonged inadequate intake, a dangerous metabolic derangement can occur. As insulin levels rise in response to exogenous carbohydrate and glucose, phosphate, potassium, and magnesium shift intracellularly for ATP and nucleotide synthesis (critical for anabolic processes). This causes severe hypokalemia, hypophosphatemia, and hypomagnesemia despite total body depletion of these minerals, leading to arrhythmias, seizures, and respiratory failure. The refeeding syndrome is a medical emergency requiring careful monitoring and slow advancement of nutritional support. This is particularly important to recognize in severely malnourished patients.

Indications for specialized nutritional support (EN or PN)

• Gastrointestinal tract dysfunction or inaccessibility: Conditions preventing safe or adequate oral intake necessitate EN or PN. Anatomical disruption (post-esophagectomy, gastrectomy, or small bowel resection), severe dysphagia from neurologic disorders (amyotrophic lateral sclerosis, severe stroke), mechanical obstruction (esophageal cancer, pyloric stenosis), or need for bowel rest (severe inflammatory bowel disease, acute pancreatitis, enterocutaneous fistula) all require specialized support. Pancreatitis is a classic indication—minimal pancreatic stimulation is required, making PN traditional, though PN is increasingly used only for severe pancreatitis with proximal small bowel inaccessibility; EN via post-pyloric tube may be tolerated. Patients with high-output enterocutaneous fistulas (>200 mL/day) often require PN to allow bowel rest and fistula closure, though selected fistulas may tolerate distal feeding.

• Severe malnutrition or malabsorption: Patients with severe protein-calorie malnutrition (characterized by albumin <2.5 g/dL, prealbumin <20 mg/dL, loss of >10% body weight over 6 months, or BMI <18.5 kg/m² in non-elderly) who cannot meet requirements orally require nutritional support. Malabsorption syndromes (celiac disease, tropical sprue, Whipple's disease, pancreatic insufficiency) may require EN with hydrolyzed formulas or peptide-based products that are more easily absorbed; if severe, PN may be needed. Short bowel syndrome from extensive small bowel resection causes permanent malabsorption requiring long-term PN or EN depending on residual absorptive capacity and adaptation time.

• Critical illness and metabolic stress: Severely septic patients, those with major burns (>20% body surface area), polytrauma, or major surgery develop profound catabolism and increased protein and energy requirements (30-40% above baseline). These patients often cannot achieve adequate oral intake acutely. EN is strongly preferred if tolerated due to immune benefits and lower infection rates, though PN is necessary if EN fails or GI tract is not functional. ARDS patients often require sedation/paralysis making oral intake impossible, necessitating EN or PN.

• Prolonged inability to eat (>7-10 days): Any condition causing prolonged cessation of oral intake—mechanical ventilation with inability to tolerate oral intake, severe cognitive impairment, persistent nausea/vomiting, or recovery from major surgery—requires nutritional support if anticipated to persist beyond 7-10 days (the time at which endogenous stores become inadequate). Short-term fasting in previously well-nourished individuals may be tolerated briefly, but support should be initiated earlier in malnourished or hypermetabolic patients.

• Critical care and postoperative patients: ICU admission is an indication to assess nutritional needs; if enteral access is possible, EN should be initiated. High-risk surgical patients (major resection, high APACHE score, significant preoperative malnutrition) benefit from perioperative nutritional support. Preoperative PN is indicated for severely malnourished patients (serum albumin <2.5 g/dL) requiring major surgery if 7-10 days' preparation time is available.

• Cancer and chemotherapy/radiation: Patients undergoing chemotherapy or radiation therapy often develop mucositis, dysgeusia, nausea, and vomiting preventing adequate oral intake. Esophageal, head/neck, or gastric cancers may cause mechanical obstruction. These patients require nutritional support to maintain strength, immune function, and tolerance of cancer therapies. EN via feeding tube is preferred if the small bowel is unaffected; PN is used if small bowel is involved.

• Neurologic disorders affecting swallowing and feeding: Amyotrophic lateral sclerosis, Parkinson's disease with advanced dysphagia, cerebral palsy, severe stroke, and Alzheimer's disease with advanced cognitive decline may necessitate feeding tubes for long-term nutritional support. Dementia patients at high risk of aspiration may benefit from careful evaluation for EN vs. comfort care measures.

Clinical manifestations of malnutrition and assessment for need for specialized nutritional support

• Cardinal presentation: Weight loss and muscle wasting: Progressive weight loss exceeding 5% over 1 month, 7.5% over 3 months, or 10% over 6 months indicates significant malnutrition. Loss of lean body mass is evidenced by temporal muscle wasting, prominence of ribs and vertebral prominences, and wasting of interosseous muscles of the hands. This represents proteolysis with depletion of structural and functional proteins needed for immunity, wound healing, and organ function. Severity correlates with mortality risk.

• Physical exam findings of visceral protein depletion: Hypoalbuminemia (<3.5 g/dL) manifests as edema (from reduced oncotic pressure), ascites (in severe cases), and poor wound healing. Loss of hair luster, hair loss, and brittle nails reflect zinc and protein deficiency. Skin changes including follicular hyperkeratosis (vitamin C deficiency), dermatitis (niacin, zinc, essential fatty acid deficiency), and delayed wound healing are common. Glossitis (inflamed tongue), angular cheilitis (cracks at mouth corners), and stomatitis reflect B vitamin and iron deficiency.

• Functional decline and weakness: Generalized weakness and fatigue result from loss of contractile protein in skeletal muscle and impaired ATP production. Decreased hand grip strength (measured by dynamometry; <80% of predicted is abnormal) correlates with malnutrition and predicts complications. Altered gait, decreased ambulation tolerance, and falls reflect muscle weakness and deconditioning. Difficulty climbing stairs or rising from a chair without arm assistance indicates significant lower extremity weakness.

• Immunologic manifestations of malnutrition: Increased susceptibility to infections (pneumonia, skin infections, UTI) with prolonged hospital courses. Poor wound healing and wound dehiscence after surgery. Lack of fever response to infection (blunted inflammatory response). These reflect impaired T-cell immunity, reduced neutrophil function, and decreased antibody production.

• GI tract dysfunction requiring nutritional support: Dysphagia (difficulty swallowing) from neurologic causes, mechanical obstruction causing inability to advance diet, persistent vomiting despite antiemetics, severe malabsorption with diarrhea despite dietary modification, severe abdominal pain with eating (pancreatic cancer, severe pancreatitis), and fecal diversion after colostomy/ileostomy may all prevent adequate oral intake.

• Signs of specific micronutrient deficiency: Wernicke's encephalopathy (ophthalmoplegia, ataxia, confusion) from thiamine deficiency, particularly in refeeding. Hypophosphatemia causing respiratory muscle weakness and weaning failure. Hypokalemia causing arrhythmias or muscle weakness. Hypomagnesemia causing personality changes, tremor, and arrhythmias. Zinc deficiency manifesting as alopecia, dermatitis, diarrhea, and impaired immunity.

• Clinical variants and special presentations: Refeeding syndrome presents as acute hypokalemia, hypophosphatemia, and hypomagnesemia with seizures, arrhythmias, or sudden cardiovascular collapse within 1-2 weeks of initiating nutrition in severely malnourished patients. Sepsis from translocation may present as fever, septic shock, and positive blood cultures in patients on prolonged PN without enteral stimulation. PN cholestasis (see complications) presents as progressive hyperbilirubinemia and abnormal liver enzymes in patients on long-term PN.

Assessment of nutritional status and determination of nutritional requirements

• Nutritional assessment tools and anthropometric measurements: The Subjective Global Assessment (SGA) is a validated clinical tool combining history (weight change, dietary intake, GI symptoms, functional capacity) and physical examination findings (fat stores, muscle mass, edema, ascites) to classify patients as well-nourished, moderately malnourished, or severely malnourished. SGA independently predicts complications and mortality. Body Mass Index (BMI) = weight (kg) / height² (m²) classifies patients (normal 18.5-24.9, overweight 25-29.9, obese ≥30 kg/m²); however, BMI may be unreliable in fluid-overloaded or amputee patients. Percentage weight loss = [(usual weight - current weight) / usual weight] × 100; >10% loss over 6 months indicates malnutrition. Triceps skinfold thickness and mid-arm muscle circumference estimate fat and muscle mass but are operator-dependent and less commonly used.

• Serum protein markers of nutritional status: Serum albumin (normal 3.5-5.0 g/dL) has a half-life of 20 days; hypoalbuminemia (<3.5 g/dL) indicates chronic protein depletion but is influenced by liver function, inflammation (albumin is a negative acute phase reactant), and fluid status, limiting specificity for malnutrition. Prealbumin (transthyretin) (normal 20-40 mg/dL) has a half-life of 2-3 days and is a more sensitive marker of recent nutritional change and nutritional repletion response; <20 mg/dL suggests significant protein depletion. Nitrogen balance = [(protein intake in grams / 6.25) - (24-hour urine urea nitrogen + 4)] assesses whether net protein is being retained (positive balance) or lost (negative balance); during acute illness, negative balance of -5 to -10 g is expected despite nutritional support due to hypermetabolism.

• Energy expenditure calculation and macronutrient requirements: The Harris-Benedict equation estimates basal energy expenditure (BEE): for men, BEE = 66.5 + (13.75 × weight in kg) + (5.0 × height in cm) - (6.76 × age); for women, BEE = 655 + (9.56 × weight in kg) + (1.85 × height in cm) - (4.68 × age). Total energy expenditure = BEE × activity factor (1.0-1.2 for bedridden, 1.2-1.5 for ambulatory) × stress factor (1.1-1.2 for moderate stress/surgery, 1.3-1.5 for sepsis/burns). **

Before the first calorie is given

• Correct electrolytes and give thiamine first: In anyone at refeeding risk, replete potassium, phosphate, and magnesium and administer thiamine (e.g., 100 mg IV) before dextrose exposure, since carbohydrate-driven insulin release drives these ions intracellularly and consumes thiamine as a cofactor for pyruvate dehydrogenase. The ASPEN 2020 consensus on refeeding syndrome advises starting at roughly 10–20 kcal/kg (or ~100–150 g dextrose) on day 1 and advancing over 3–5 days with daily electrolyte monitoring.
• Resuscitate before feeding: Feeding is deferred in shock until the patient is fluid-resuscitated and hemodynamically stabilizing (ASPEN/SCCM critical care nutrition guidelines).

First-line therapy — enteral nutrition

• "If the gut works, use it": ASPEN/SCCM recommend initiating EN within 24–48 hours in critically ill patients who cannot eat, using a standard polymeric formula via a nasogastric tube. EN preserves mucosal mass, secretory IgA, and barrier integrity.
• Access by expected duration: Nasogastric/nasoenteric tubes for short-term use; percutaneous endoscopic gastrostomy (PEG) or surgical/radiologic gastrostomy or jejunostomy when support is expected beyond about 4 weeks.
• Escalation for intolerance: Try prokinetics (dopamine antagonist metoclopramide or the motilin agonist erythromycin), then post-pyloric/jejunal tube placement, before abandoning EN. ASPEN/SCCM advise against routinely holding feeds for gastric residual volumes alone.

Second-line — parenteral nutrition

• Indications and timing: PN when the gut is unusable (obstruction, ischemia, high-output fistula, short bowel). In well-nourished, low-risk patients ASPEN/SCCM recommend withholding PN for about the first week; in severely malnourished/high-nutrition-risk patients start PN early when EN is not feasible.
• Composition and access: Dextrose, amino acids, and lipid emulsion plus electrolytes, multivitamins, and trace elements through a central catheter (hypertonic); peripheral PN only for short-term, low-osmolarity formulations. Add insulin, targeting the SCCM/ADA inpatient range of roughly 140–180 mg/dL.
• Definitive options: Bowel rehabilitation with the GLP-2 analog teduglutide in short bowel syndrome; intestinal transplantation for irreversible intestinal failure with PN-related liver failure or loss of venous access.

Contraindicated

• EN: mechanical obstruction, bowel ischemia, or escalating high-dose vasopressor requirement (risk of non-occlusive mesenteric ischemia).
• PEG in advanced dementia: AGA/American Geriatrics Society Choosing Wisely advises hand feeding instead — tube feeding does not improve survival or aspiration risk.

Metabolic (both routes)

• Refeeding syndrome — emergency: Insulin surge drives phosphate, potassium, and magnesium intracellularly; signalled by falling serum phosphate within 24–72 hours of feeding, then arrhythmia, respiratory muscle failure, seizures, or cardiovascular collapse. Hold/reduce calories, replete aggressively, give thiamine.
• Hyperglycemia: Dextrose load exceeding oxidative capacity; predisposes to infection and osmotic diuresis.
• Rebound hypoglycemia: Abrupt PN discontinuation with persistent endogenous hyperinsulinemia — taper the infusion or bridge with dextrose-containing fluid.
• Overfeeding and hypercapnia: Excess carbohydrate raises the respiratory quotient and CO2 production; the clue is failure to wean from the ventilator with rising PaCO2.
• Hypertriglyceridemia / fat overload: Lipid clearance exceeded — check triglycerides; can precipitate pancreatitis.
• Micronutrient problems: Essential fatty acid deficiency with fat-free PN (scaly dermatitis, elevated triene:tetraene ratio); zinc, copper, and selenium deficiency on long-term PN; manganese accumulation contributing to cholestasis and parkinsonism.

Catheter- and PN-specific

• Central line-associated bloodstream infection — emergency: New fever, leukocytosis, or hyperglycemia in a PN patient; draw paired peripheral and catheter blood cultures. Coagulase-negative staphylococci, S. aureus, and Candida predominate; the lipid-rich, glucose-rich hub favors candidemia.
• Insertion and mechanical complications: pneumothorax, arterial puncture, catheter-related venous thrombosis, air embolism (emergency), and loss of venous access in long-term PN.
• Intestinal failure–associated liver disease: Gut disuse plus phytosterol-rich soybean lipid and lack of enteral CCK stimulation produce steatosis then cholestasis — rising conjugated bilirubin and alkaline phosphatase. Biliary sludge and acalculous cholecystitis follow the same mechanism. Metabolic bone disease occurs with years of PN.

Enteral-specific

• Tube malposition into the tracheobronchial tree — emergency: Feeding through a misplaced tube causes chemical pneumonitis; radiographic confirmation is required before first use (auscultation of insufflated air is unreliable).
• Aspiration pneumonia: Gastric feeding with impaired airway protection; elevate the head of bed 30–45°.
• Diarrhea: Usually hyperosmolar formula, rapid infusion, or sorbitol-containing liquid medications — consider C. difficile before blaming the formula.
• Tube clogging, peristomal infection, leak, and buried bumper syndrome with gastrostomy tubes.
• Drug–feed interactions: Reduced absorption of phenytoin, levothyroxine, and fluoroquinolones; vitamin K content antagonizes warfarin.

• "If the gut works, use it": EN beats PN on infectious complications and cost whenever the GI tract is usable; ASPEN/SCCM want EN started within 24–48 hours in the critically ill. The commonest distractor is starting TPN in a patient who simply has a poor appetite or a few days of NPO status — a previously well-nourished patient tolerates about a week without specialized support.
• Single best next step after tube placement: confirm position by radiograph before feeding. Auscultating insufflated air over the epigastrium is the classic wrong answer.
• Hypophosphatemia is the fingerprint of refeeding syndrome: falling phosphate (with potassium and magnesium) days after feeds begin in a chronically starved patient — anorexia nervosa, alcohol use disorder, post-bariatric, prolonged NPO. Give thiamine before glucose to avoid precipitating Wernicke encephalopathy.
• Fever plus a central line plus TPN = catheter infection until proven otherwise: paired peripheral and catheter blood cultures are the next step; think Candida and coagulase-negative staphylococci.
• Abrupt TPN cessation causes rebound hypoglycemia — taper or run dextrose. Conversely, unexplained hyperglycemia in a stable PN patient can be the first sign of sepsis.
• Failure to wean from the ventilator on nutrition support: suspect overfeeding — excess carbohydrate raises CO2 production. Reduce total calories rather than increasing minute ventilation on the exam.
• Severe acute pancreatitis is an EN, not TPN, question: early enteral feeding (gastric or post-pyloric) is favored over parenteral nutrition; "bowel rest with TPN" is the outdated distractor.
• Advanced dementia: AGA and the American Geriatrics Society recommend careful hand feeding, not PEG — tubes do not reduce aspiration or improve survival. Contrast with ALS and head/neck cancer, where gastrostomy is appropriate.
• Long-term PN associations to recognize: cholestasis and biliary sludge, essential fatty acid deficiency (elevated triene:tetraene ratio), and metabolic bone disease.